• Epclusa

    Drug: Epclusa (ep-KLOO-suh)

    Summary

    ep3
    Epclusa is a combination of two drugs—sofosbuvir, a polymerase inhibitor and velpatasvir, a NS5A inhibitor, combined into one pill, taken once-a-day.Epclusa is taken with or without food. Epclusa is approved by the Food and Drug Administration to treat adults infected with chronic hepatitis C (HCV) genotype 1, 2, 3, 4, 5 and 6.It can be taken with and without ribavirin. Epclusa is manufactured by Gilead Sciences Inc.

    The overall cure rates of Epclusa are up to and over 90%.The wholesale acquisition cost (WAC) for Epclusa is $74,760.00 for a ...

  • Zepatier

    Drug:  Zepatier (ZEP-ah-teer)

    Summary

    Zepatier
    Zepatier is a combination of two drugs—elbasvir (NS5A inhibitor) and grazoprevir (protease inhibitor) combined into one pill, taken once-a-day.  Zepatier is taken with or without food.   Zepatier is approved by the Food and Drug Administration to treat adults infected with chronic hepatitis C (HCV) genotype 1 and 4.  It can be taken with and without ribavirin.   Zepatier is manufactured by Merck & Co. Inc.

    The overall cure rates of Zepatier are up to and over 90%.  The wholesale acquisition cost (WAC) for Zepatier is $54,600 for a ...

  • Technivie

    Drug: Technivie (TEK-ni-vee)

    Summary

    Technivie imageTechnivie is a combination of 3 drugs combined into one pill approved by the Food and Drug Administration (FDA) to treat chronic hepatitis C genotype 4.  The drugs include:

    • Ombitasvir  (NS5A inhibitor)
    • Paritaprevir (protease inhibitor)/ritonavir (protease inhibitor)

     

    Technivie is taken twice a day with ribavirin with food.  The treatment duration is 12 weeks.

    The overall cure rates of Technivie is  91% to 100%.  The wholesale acquisition cost (WAC) for a 12-week treatment course of Technivie is $76, 653. It is taken for 12 weeks based on clinical trial ...

  • Harvoni

    Drug: Harvoni (har-VOE-nee)

    Summary

    harvoni image

    Harvoni is a combination of two drugs – ledipasvir (NS5A inhibitor) and sofosbuvir (polymerase inhibitor) combined into one pill, taken once-a-day. Harvoni is taken with or without food. Harvoni is approved by the Food and Drug Administration to treat adults infected with hepatitis C (HCV) genotype 1, 4, 5 and 6. It can be taken with and without ribavirin. Harvoni is manufactured by Gilead Sciences Inc.

    The overall cure rates of Harvoni are up to and over 90%. The wholesale acquisition cost (WAC) for Harvoni is $1,125 per pill. It ...